These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy. Marchant V, Droguett A, Valderrama G, Burgos ME, Carpio D, Kerr B, Ruiz-Ortega M, Egido J, Mezzano S. Am J Physiol Renal Physiol; 2015 Sep 15; 309(6):F559-68. PubMed ID: 26155842 [Abstract] [Full Text] [Related]
23. Beneficial effect on podocyte number in experimental diabetic nephropathy resulting from combined atrasentan and RAAS inhibition therapy. Hudkins KL, Wietecha TA, Steegh F, Alpers CE. Am J Physiol Renal Physiol; 2020 May 01; 318(5):F1295-F1305. PubMed ID: 32249614 [Abstract] [Full Text] [Related]
24. Carnosinase, diabetes mellitus and the potential relevance of carnosinase deficiency. Peters V, Zschocke J, Schmitt CP. J Inherit Metab Dis; 2018 Jan 01; 41(1):39-47. PubMed ID: 29027595 [Abstract] [Full Text] [Related]
25. Kidney glycosphingolipids are elevated early in diabetic nephropathy and mediate hypertrophy of mesangial cells. Subathra M, Korrapati M, Howell LA, Arthur JM, Shayman JA, Schnellmann RG, Siskind LJ. Am J Physiol Renal Physiol; 2015 Aug 01; 309(3):F204-15. PubMed ID: 26041445 [Abstract] [Full Text] [Related]
26. Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes. Yuan H, Lanting L, Xu ZG, Li SL, Swiderski P, Putta S, Jonnalagadda M, Kato M, Natarajan R. Am J Physiol Renal Physiol; 2008 Aug 01; 295(2):F605-17. PubMed ID: 18562637 [Abstract] [Full Text] [Related]
27. Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. Janssen B, Hohenadel D, Brinkkoetter P, Peters V, Rind N, Fischer C, Rychlik I, Cerna M, Romzova M, de Heer E, Baelde H, Bakker SJ, Zirie M, Rondeau E, Mathieson P, Saleem MA, Meyer J, Köppel H, Sauerhoefer S, Bartram CR, Nawroth P, Hammes HP, Yard BA, Zschocke J, van der Woude FJ. Diabetes; 2005 Aug 01; 54(8):2320-7. PubMed ID: 16046297 [Abstract] [Full Text] [Related]
28. A diet containing cod backbone proteins attenuated the development of mesangial sclerosis and tubular dysfunction in male obese BTBR ob/ob mice. O'Keeffe M, Oterhals Å, Weishaupt H, Leh S, Ulvik A, Ueland PM, Halstensen A, Marti HP, Gudbrandsen OA. Eur J Nutr; 2023 Dec 01; 62(8):3227-3240. PubMed ID: 37550593 [Abstract] [Full Text] [Related]
30. Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats. Boor P, Celec P, Behuliak M, Grancic P, Kebis A, Kukan M, Pronayová N, Liptaj T, Ostendorf T, Sebeková K. Metabolism; 2009 Nov 01; 58(11):1669-77. PubMed ID: 19608208 [Abstract] [Full Text] [Related]
31. [Carnosine, carnosinase and kidney diseases]. Kiliś-Pstrusińska K. Postepy Hig Med Dosw (Online); 2012 Apr 20; 66():215-21. PubMed ID: 22706107 [Abstract] [Full Text] [Related]
32. Treatment with the matricellular protein CCN3 blocks and/or reverses fibrosis development in obesity with diabetic nephropathy. Riser BL, Najmabadi F, Garchow K, Barnes JL, Peterson DR, Sukowski EJ. Am J Pathol; 2014 Nov 20; 184(11):2908-21. PubMed ID: 25193594 [Abstract] [Full Text] [Related]
33. PLVAP as an Early Marker of Glomerular Endothelial Damage in Mice with Diabetic Kidney Disease. Wolf EE, Steglich A, Kessel F, Kröger H, Sradnick J, Reichelt-Wurm S, Eidenschink K, Banas MC, Wolf E, Wanke R, Gembardt F, Todorov VT. Int J Mol Sci; 2023 Jan 06; 24(2):. PubMed ID: 36674624 [Abstract] [Full Text] [Related]
34. Low plasma carnosinase activity promotes carnosinemia after carnosine ingestion in humans. Everaert I, Taes Y, De Heer E, Baelde H, Zutinic A, Yard B, Sauerhöfer S, Vanhee L, Delanghe J, Aldini G, Derave W. Am J Physiol Renal Physiol; 2012 Jun 15; 302(12):F1537-44. PubMed ID: 22496410 [Abstract] [Full Text] [Related]
35. Klotho attenuates renal hypertrophy and glomerular injury in Ins2Akita diabetic mice. Kadoya H, Satoh M, Haruna Y, Sasaki T, Kashihara N. Clin Exp Nephrol; 2016 Oct 15; 20(5):671-678. PubMed ID: 26586006 [Abstract] [Full Text] [Related]
36. Single-cell transcriptomics reveals a mechanosensitive injury signaling pathway in early diabetic nephropathy. Liu S, Zhao Y, Lu S, Zhang T, Lindenmeyer MT, Nair V, Gies SE, Wu G, Nelson RG, Czogalla J, Aypek H, Zielinski S, Liao Z, Schaper M, Fermin D, Cohen CD, Delic D, Krebs CF, Grahammer F, Wiech T, Kretzler M, Meyer-Schwesinger C, Bonn S, Huber TB. Genome Med; 2023 Jan 10; 15(1):2. PubMed ID: 36627643 [Abstract] [Full Text] [Related]
37. Rodent models to study type 1 and type 2 diabetes induced human diabetic nephropathy. Talukdar A, Basumatary M. Mol Biol Rep; 2023 Sep 10; 50(9):7759-7782. PubMed ID: 37458869 [Abstract] [Full Text] [Related]
39. Mannan-Binding Lectin Is Associated with Inflammation and Kidney Damage in a Mouse Model of Type 2 Diabetes. Dørflinger GH, Holt CB, Thiel S, Bech JN, Østergaard JA, Bjerre M. Int J Mol Sci; 2024 Jun 29; 25(13):. PubMed ID: 39000309 [Abstract] [Full Text] [Related]
40. Grem2 mediates podocyte apoptosis in high glucose milieu. Wen H, Kumar V, Mishra A, Song S, Aslam R, Hussain A, Wang H, Zhou X, He X, Wu G, Luo H, Lan X, Malhotra A, Singhal PC. Biochimie; 2019 May 29; 160():113-121. PubMed ID: 30831151 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]